［1］Mehr MA, Azimi A，Mollapour A, et al. Epidemiology of multi drug resistant bacteria in Mechanically Ventilated Patients at intensive care units of trauma and surgery hospital in Qazvin［J］.Tabriz University of Medical Sciences, 2011,1(4):258-265.
［2］孙长贵.抗微生物药物敏感性试验执行标准［J］.中华检验医学杂志，2010,30(1)：40-41，64-65.
［3］黄勋，邓子德，倪语星，等.多重耐药菌医院感染预防与控制中国专家共识［J］.中国感染控制杂志，2015,14(1):1-6.
［4］Kydona C, Malamis G, Sidiropoulou?N，et al. Incidence of multidrug-resistant bacteria in a general ICU: 1-year study［J］.Critical Care,2004,8(1):1-2.
［5］Munoz-Price LS, Kobert AW. Acinetobacter lnfection［J］.N Engl J Med, 2008, 358 (12):1271-281.
［6］Principe L，D'Arezzo S，Capone A,et al. Annals of clinical microbiology and antimicrobials［J］.Annals of Clinical Microbiology and Antimicrobials ,2009, 8(18):1-10.
［7］Reddy P, Chadaga S, Noskin UA. Antibiotic considerations in the treatment of multidrug-resistant(MDR) pathogens based review［J］.J Hosp Med, 2009, 4(6):8-15.
［8］avon-Venezia S,Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii［J］.J Antimicrob Chemother,2007,59（4）:772–774.
［9］陈佰义，何礼贤，胡必杰，等.中国鲍曼不动杆菌感染诊治与防控专家共识［J］.中华医学杂志，2012,92(8):3-8.
［10］Wisplinghoff H，Paulus T，Lugenheim M, et al. Nosocomial bloodstream infections due to Acinetobacter baumanii，Acinctobactcr pittii and Acinctobactcr nosocomialis in the United States［J］.J Infect,2012,64(3)：282-290. |
